Ensuring Your Safety
All trials through Dartmouth College, The Geisel School of Medicine at Dartmouth, and Dartmouth-Hitchcock Medical Center are conducted according to strict scientific and ethical principles.
Every clinical trial has a plan, called a protocol, describing what will happen in the study and why it is necessary. Before a trial begins, a committee reviews the protocol and approves it only if the clinical trial meets certain standards.
At Dartmouth-Hitchcock Health, this group is called the Human Research Protection Program (HRPP). The committee evaluates the scientific basis for the trial, the risks to participants, and the information participants receive.
The HRPP continues to oversee the study while it is in progress, and can stop a trial that does not meet their approval or is causing unexpected harm to participants. They also can halt a clinical trial if the treatment being studied is very effective, in order to make it available sooner to patients who are not on the trial.